AzTrials
AzTrials

Corticospinal ExcitabilityLAMINCT06478303

LAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension

An observational study of Corticospinal Excitability and Cortical Activation, run by University Hospital, Grenoble at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
Motor imagery, Action reading and Motor localizer
How many people
105 participants
Where
2 sitesFrance
Study dates
27 Jul 2024to 26 Jul 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Subjects will be aged between 18 and 40, reading and understanding French, with no neurological or psychiatric disorders, no uncorrected vision deficits, and meeting all MRI or TMS examination criteria. they were recruited at the University of Burgundy (TMS measures only) and the University of Grenoble Alpes (fMRI measures only).

Who may be able to join

  • persons who have given written consent,
  • healthy subjects
  • subjects reading and understanding French
  • right-handed,
  • affiliated with a social security system,
  • between 18 and 40 years old,
  • had completed the TMS inclusion questionnaire or had undergone a medical examination prior to participation in the MRI study.

Who cannot join

  • Existence of a severe general medical condition: cardiac, respiratory, hematological, renal, hepatic, cancerous,
  • Regular use of anxiolytics, sedatives, antidepressants, neuroleptics,
  • Characterized psychiatric pathology,
  • Ingestion of alcohol prior to the examination,
  • Persons covered by articles L1121-5 to L1121-8 of the CSP,
  • Presence of contraindications to MRI or TMS.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France2 sites, 2 recruiting
  • Université de Bourgogne

    Dijon

    Florent LEBON, +33 (0)3 80 39 67 54, Florent.Lebon@u-bourgogne.fr

    William DUPONT, +33 (0)6 67 76 00 99, william.dupont@univ-grenoble-alpes.fr

    Recruiting
  • CHU Grenoble Alpes

    Grenoble, Grenob, 38043

    Laurent VERCUEIL, +33 (0)4 76 76 55 61, LVercueil@chu-grenoble.fr

    William DUPONT, +33 (0)6 67 76 00 99, william.dupont@univ-grenoble-alpes.fr

    Recruiting

Other trials in France

About this study

Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. For instance, motor training (e.g., sports, origami training) can facilitate action verb recognition, whereas motor deficits (e.g., upper limb immobilization) can hinder the processing of action language. Similarly, action language has been shown to affect motor performance. These effects are attributed to an implicit form of motor imagery, an automatic simulation of motor experience (without actual movement) evoked by action words. Interestingly, literature supports the idea that the motor simulations used for imagining an action are also engaged during the reading of action language, leading to similar neurophysiological and behavioral changes in both processes. However, questions remain about the similarity of the simulations generated by motor imagery and action language. This project, encompassing three experimental sequences, aims to address these questions to achieve significant scientific advancements in both theoretical and applied domains.

Being tested
Motor imagery, Action reading, Motor localizer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor imageryOther

    Participants were asked to imagine arm or foot movements.

  • Action readingOther

    Participants were asked to read sentences involving arm or foot movements

  • Motor localizerOther

    Participants were asked to perform arm or foot movements

Study groups in NCT06478303
Study groupRoleWhat they receive
TMS Experimental groupNot described
Receives: Other: Motor imagery; Other: Action reading
fMRI Experimental groupNot described
Receives: Other: Motor imagery; Other: Action reading; Other: Motor localizer
Experimental ccPAS groupNot described
Receives: Other: Motor imagery; Other: Action reading
Sham ccPAS groupNot described
Receives: Other: Motor imagery; Other: Action reading
control groupNot described
Receives: Other: Motor imagery; Other: Action reading

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of corticospinal excitability

    this is a physiological response obtained by transcranial magnetic pulses (TMS). This is an indicator of the excitability of the motor system, which can be used at rest or during various cognitive tasks (motor imagery or action reading).

    Measured: 1 hour and 30 minutes

  2. Cortical activation (BOLD signal)

    this is a cortical response obtained via a fMRI. This is an indicator of the brain activity, which can be used at rest or during motor and cognitive tasks (motor imagery or action reading).

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2024
  2. Study start27 Jul 2024
  3. Primary completion26 Jul 2027 (estimated)
  4. Study completion26 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06478303
Sponsor's protocol ID
38RC23.0349
Other IDs
2023-A02322-43
Acronym
LAMI
Status last verified
Sep 2026
First submitted
13 Jun 2024
Last updated
2 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Corticospinal Excitability and Cortical Activation, run by University Hospital, Grenoble at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laurent VERCUEIL (0476765561, LVercueil@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of corticospinal excitability (time frame: 1 hour and 30 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in